<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04891211</url>
  </required_header>
  <id_info>
    <org_study_id>EA180919</org_study_id>
    <nct_id>NCT04891211</nct_id>
  </id_info>
  <brief_title>Retinal Changes in Vitamin D Deficiency</brief_title>
  <acronym>VDD</acronym>
  <official_title>Evaluation of Retinal Structure in Pediatric Subjects With Vitamin D Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Adiyaman University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Adiyaman University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retinal tissue parameters of pediatric patients with vitamin D deficiency will be evaluated&#xD;
      in this prospective case-control study. The patients will be divided into 2 groups according&#xD;
      to the vitamin D level. Retinal vessel diameters, retinal nerve fiber evaluation, choroidal&#xD;
      thickness will be evaluated. Choroidal thinning decrease in retinal artery diameter and&#xD;
      increase in retinal vein diameter will be detected in the vitamin D deficiency group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study of the relationship between vitamin D status and retinal diseases is a new concept,&#xD;
      and there is a large gap in research focusing on the pediatric population in the literature.&#xD;
      The importance of vitamin D in retinal maturation and its role in the development of retinal&#xD;
      diseases at a young age is being investigated. In this sense, as far as known, it is the&#xD;
      first study investigating retinal structure parameters in pediatric patients with vitamin D&#xD;
      deficiency.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 12, 2021</start_date>
  <completion_date type="Actual">March 10, 2021</completion_date>
  <primary_completion_date type="Actual">March 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Group 1: 1) age &lt;18 years old; 2) serum vitamin D [(25(OH) D), calcitriol] level &lt;20 ngr/mL in previous two weeks Group 2: 1) age &lt;18 years old; 2) serum vitamin D [(25(OH) D), calcitriol] level &gt;20 ngr/mL in previous two weeks</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Patients will be examined without knowing their vitamin D level. The OCT evaluations will be performed by a highly trained ophthalmic technician, and the compatibility of the results will be confirmed by two experienced retinal specialists.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>choroidal thickness</measure>
    <time_frame>up to 3 months</time_frame>
    <description>subfoveal, and subfoveal 1500-µm- and 3000-µm-diameter distance nasal and temporal areas</description>
  </primary_outcome>
  <primary_outcome>
    <measure>retinal nerve fiber layer</measure>
    <time_frame>up to 3 months</time_frame>
    <description>Retinal nerve fiber layer will be detected by optical coherence tomography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The central retinal artery and vein calibers</measure>
    <time_frame>up to 3 months</time_frame>
    <description>The central retinal artery and vein calibers will be analyzed with the Interactive Vessel Analyzer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood vitamin D levels</measure>
    <time_frame>up to 3 months</time_frame>
    <description>vitamin D deficiency or normal effects of vitamin D deficiency</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Pediatric Disorder</condition>
  <condition>Vitamin D Deficiency</condition>
  <condition>Retinal Disease</condition>
  <condition>Choroidal Disease</condition>
  <condition>Optic Nerve Diseases</condition>
  <arm_group>
    <arm_group_label>Pediatric endocrinologist</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient selection by pediatric endocrinologist on the basis of vitamin D</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ophthalmologist</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Evaluation of the results by 2 different retina specialists during the examination of patients&#xD;
Interpretation of the results without knowing the vitamin D level of patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D deficiency</intervention_name>
    <description>Ocular significance of vitamin D deficiency in pediatric cases</description>
    <arm_group_label>Pediatric endocrinologist</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:(Group 1):&#xD;
&#xD;
          1. age &lt;18 years old&#xD;
&#xD;
          2. serum vitamin D [(25(OH) D), calcitriol] level &lt;20 ngr/mL in previous two weeks&#xD;
&#xD;
          3. visual acuity &gt;20/20&#xD;
&#xD;
          4. manifest refraction spherical equivalent &lt;3D&#xD;
&#xD;
          5. normal biomicroscopic and fundus examination.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. history of any chronic ocular diseases, except for refractive error (e.g., uveitis,&#xD;
             glaucoma, retinopathy of prematurity)&#xD;
&#xD;
          2. history of ocular surgery (e.g., cataract, strabismus, open globe injury, laser&#xD;
             photocoagulation)&#xD;
&#xD;
          3. having an ocular abnormality (e.g., persistent fetal vasculature, optic disc&#xD;
             hypoplasia, fovea plana)&#xD;
&#xD;
          4. history of systemic diseases that have the potential to affect ocular tissues (e.g.,&#xD;
             diabetes mellitus, Graves' disease, albinism, Down syndrome, Fabry diseases, Wilson&#xD;
             syndrome)&#xD;
&#xD;
          5. history of any systemic diseases that can affect the serum vitamin D level (e.g.,&#xD;
             parathormone or calcium metabolism disorders)&#xD;
&#xD;
          6. already receiving vitamin D treatment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pediatrics population</gender_description>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emre Aydemir, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Adiyaman University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Adıyaman U</name>
      <address>
        <city>Adıyaman</city>
        <state>None Selected</state>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Poon M, Craig ME, Kaur H, Cusumano J, Sasongko MB, Wong TY, Donaghue KC. Vitamin D deficiency is not associated with changes in retinal geometric parameters in young people with type 1 diabetes. J Diabetes Res. 2013;2013:280691. doi: 10.1155/2013/280691. Epub 2013 Jul 7.</citation>
    <PMID>23936865</PMID>
  </results_reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 11, 2021</study_first_submitted>
  <study_first_submitted_qc>May 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>May 13, 2021</last_update_submitted>
  <last_update_submitted_qc>May 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Adiyaman University</investigator_affiliation>
    <investigator_full_name>Emre Aydemir</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Optic Nerve Diseases</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Choroid Diseases</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Participants will be told what the plan provided and how it worked. Information will be given about when he will participate in the study and the measurements to be taken for the study.&#xD;
It will be emphasized that there was nothing that harmed the participants in the examinations.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Participants will be examined at same times of the day in order not to affect the measurement results.</ipd_time_frame>
    <ipd_access_criteria>Participants will be divided into groups according to their vitamin D levels</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

